The global lateral lumbar interbody fusion market will likely grow at a compound annual growth rate of 5.7 percent between 2017 and 2024, according to a Data Bridge Market Research analysis.
NuVasive's XLIF procedure is backed by 10-plus years of clinical evidence.
Here are four observations:
1. The market is set to hit about $2.6 billion by 2024.
2. In 2016, the market was worth about $1.6 billion.
3. Key drivers include the increasing demand of minimally invasive procedures and growing number of spinal disorder cases.
4. The procedure's costliness, unfavorable reimbursements and a boost in alternative treatments will hinder market growth.